Growth hormone secretion and immunological function of a male patient with a homozygous STAT5b mutation

European Journal of Endocrinology

Volumn 156, Issue 2, 2007, Pages 155-165

  Walenkamp, Marie J E ^a   Vidarsdottir, Solrun ^a   Pereira, Alberto M ^a   Karperien, Marcel ^a   van Doorn, Jaap ^b   van Duyvenvoorde, Hermine A ^a   Breuning, Martijn H ^a   Roelfsema, Ferdinand ^a   Kruithof, M Femke ^a   van Dissel, Jaap ^a   Janssen, Riny ^a   Wit, Jan M ^a   Romijn, Johannes A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GROWTH HORMONE; HUMAN GROWTH HORMONE; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; PROLACTIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C; STAT5B PROTEIN; TUMOR NECROSIS FACTOR ALPHA; IGFBP3 PROTEIN, HUMAN; INTERFERON RECEPTOR; SOMATOMEDIN BINDING PROTEIN; STAT5 PROTEIN; STAT5B PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY FAT; CASE REPORT; CONTROLLED STUDY; DELAYED PUBERTY; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; GROWTH RETARDATION; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; IMMUNE RESPONSE; IMMUNE STATUS; IN VITRO STUDY; LEUKOCYTE FUNCTION; LYMPHOCYTE FUNCTION; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; PROTEIN BLOOD LEVEL; SHORT STATURE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ADOLESCENT; BLOOD; BODY HEIGHT; CELL CULTURE; CELL DIVISION; CHILD; CYTOLOGY; DRUG EFFECT; GENETICS; HOMOZYGOTE; IMMUNOLOGY; METABOLISM; PHENOTYPE; SECRETION;

ADOLESCENT; BODY HEIGHT; CELL DIVISION; CELLS, CULTURED; CHILD; HOMOZYGOTE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12 SUBUNIT P40; LIPOPOLYSACCHARIDES; MONOCYTES; PHENOTYPE; PROLACTIN; RECEPTORS, INTERFERON; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33947729366     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02327     Document Type: Article

References (46)

1. Herrington J & Carter-Su C. Signaling pathways activated by the growth hormone receptor. Trends in Endocrinology and Metabolism 2001 12 252-257.
2. Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G & Ihle JN. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 1998 93 841-850.
3. Welte T, Leitenberg D, Dittel BN, Al Ramadi BK, Xie B, Chin YE, Janeway CA Jr, Bothwell AL, Bottomly K & Fu XY. STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation. Science 1999 283 222-225.
4. Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, Pratt KL, Bezrodnik L, Jasper H, Tepper A, Heinrich JJ & Rosenfeld RG. Growth hormone insensitivity associated with a STAT5b mutation. New England Journal of Medicine 2003 349 1139-1147.
5. Hwa V, Little B, Adiyaman P, Kofoed EM, Pratt KL, Ocal G, Berberoglu M & Rosenfeld RG. Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b. Journal of Clinical Endocrinology and Metabolism 2005 90 4260-4266.
6. Vidarsdottir S, Walenkamp MJ, Pereira AM, Karperien M, Van Doorn J, van Duyvenvoorde HA, White S, Breuning MH, Roelfsema F, Kruithof MF, van Dissel J, Janssen R, Wit JM & Romijn JA. Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation. Journal of Clinical Endocrinology and Metabolism 2006 91 3482-3485.
7. Fredriks AM, van Buuren S, Burgmeijer RJ, Meulmeester JF, Beuker RJ, Brugman E, Roede MJ, Verloove-Vanhorick SP & Wit JM. Continuing positive secular growth change in The Netherlands 1955-1997. Pediatric Research 2000 47 316-323.
8. Walenkamp W, Karperien M, Pereira AM, Hilhorst-Hofstee Y, Van Doorn J, Chen JW, Mohan S, Denley A, Forbes B, van Duyvenvoorde HA, van Thiel SW, Sluimers CA, Bax JJ, de Laat JA, Breuning MB, Romijn JA & Wit JM. Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. Journal of Clinical Endocrinology and Metabolism 2005 90 2855-2864.
9. Yu H, Mistry J, Nicar MJ, Khosravi MJ, Diamandis A, Van Doorn J & Juul A. Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation. Journal of Clinical Laboratory Analysis 1999 13 166-172.
10. Cole TJ. The LMS method for constructing normalized growth standards. European Journal of Clinical Nutrition 1990 44 45-60.
11. Veldhuis JD & Johnson ML. Deconvolution analysis of hormone data. Methods in Enzymology 1992 210 539-575.
12. Pincus SM. Approximate entropy as a measure of system complexity. PNAS 1991 88 2297-2301.
13. Veidhuis JD & Pincus SM. Orderliness of hormone release patterns: a complementary measure to conventional pulsatile and circadian analyses. European Journal of Endocrinology 1998 138 358-362.
14. Veldhuis JD, Straume M, Iranmanesh A, Mulligan T, Jaffe C, Barkan A, Johnson ML & Pincus S. Secretory process regularity monitors neuroendocrine feedback and feedforward signaling strength in humans. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2001 280 R721-R729.
15. Veldhuis JD & Johnson ML. Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. American Journal of Physiology. Endocrinology and Metabolism 1986 250 E486-E493.
16. Janssen R, van Wengen A, Hoeve MA, ten Dam M, van der BM, van Dongen J, van d V, van Tol M, Bredius R, Ottenhoff TH, Weemaes C, van Dissel JT & Lankester A. The same IkappaBalpha mutation in two related individuals leads to completely different clinical syndromes. Journal of Experimental Medicine 2004 200 559-568.
17. Niklasson A, Ericson A, Fryer JG, Karlberg J, Lawrence C & Karlberg P. An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age (1977-1981). Acta Paediatrica Scandinavica 1991 80 756-762.
18. Janssen R, van Wengen A, Verhard E, De Boer T, Zomerdijk T, Ottenhoff TH & van Dissel JT. Divergent role for TNF-alpha in IFN-gamma-induced killing of Toxoplasma gondii and Salmonella typhimurium contributes to selective susceptibility of patients with partial IFN-gamma receptor 1 deficiency. Journal of Immunology 2002 169 3900-3907.
19. Laron Z. Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome). Journal of Pediatric Endocrinology and Metabolism 1999 12 (Suppl 1) 231-249.
20. Woods KA, Camacho-Hubner C, Savage MO & Clark AJ. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. New England Journal of Medicine 1996 335 1363-1367.
21. Aynsley-Green A, Zachmann M & Prader A. Interrelation of the therapeutic effects of growth hormone and testosterone on growth in hypopituitarism. Journal of Pediatrics 1976 89 992-999.
22. Iramnanesh A, South S, Liem AY, Clemmons D, Thorner MO, Weltman A & Veldhuis JD. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men. European Journal of Endocrinology 1998 139 59-71.
23. Veldhuis JD, Iramnanesh A & Bowers CY. Joint mechanisms of impaired growth-hormone pulse renewal in aging men. Journal of Clinical Endocrinology and Metabolism 2005 90 4177-4183.
24. Giustina A & Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocrine Reviews 1998 19 717-797.
25. Farhy LS, Straume M, Johnson ML, Kovatchev B & Veldhuis JD. A construct of interactive feedback control of the GH axis in the male. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2001 281 R38-R51.
26. Farhy LS & Veldhuis JD. Deterministic construct of amplifying actions of ghrelin on pulsatile growth hormone secretion. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2005 288 R1649-R1663.
27. Bjarnason R, Banerjee K, Rose SJ, Rosberg S, Metherell L, Clark AJL, Albertsson-Wikland K & Savage MO. Spontaneous growth hormone secretory characteristics in children with partial growth hormone insensitivity. Clinical Endocrinology 2002 57 357-361.
28. Vaccarello MA, Diamond FB Jr, Guevara-Aguirre J, Rosenbloom AL, Fielder PJ, Gargosky S, Cohen P, Wilson K & Rosenfeld RG. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome. Journal of Clinical Endocrinology and Metabolism 1993 77 273-280.
29. Vance ML, Kaiser DL, Evans WS, Furlanetto R, Vale W, Rivier J & Thorner MO. Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion. Journal of Clinical Investigation 1985 75 1584-1590.
30. Jaffe CA, Friberg RD & Barkan AL. Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. Direct evidence for involvement of endogenous GHRH in the generation of GH pulses. Journal of Clinical Investigation 1993 92 695-701.
31. Hindmarsh PC, Brain CE, Robinson IC, Matthews DR & Brook CG. The interaction of growth hormone releasing hormone and somatostatin in the generation of a GH pulse in man. Clinical Endocrinology (Oxford) 1991 35 353-360.
32. Calabresi E, Ishikawa E, Bartolini L, Delitala G, Fanciulli G, Oliva O, Veldhuis JD, & Serio M. Somatostatin infusion suppresses GH secretory burst frequency and mass in normal men. American Journal of Physiology. Endocrinology and Metabolism 1996 270 E975-E979.
33. Iramnanesh A, Lizarralde G & Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. Journal of Clinical Endocrinology and Metabolism 1991 73 1081-1088.
34. Bonert VS, Elashoff JD, Barnett P & Melmed S. Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiency. Journal of Clinical Endocrinology and Metabolism 2004 89 3397-3401.
35. Pijl H, Langendonk JG, Burggraaf J, Frolich M, Cohen AF, Veldhuis JD & Meinders AE. Altered neuroregulation of GH secretion in viscerally obese premenopausal women. Journal of Clinical Endocrinology and Metabolism 2001 86 5509-5515.
36. Roemmich JN, Clark PA, Weltman A, Veldhuis JD & Rogol AD. Pubertal alterations in growth and body composition: IX. Altered spontaneous secretion and metabolic clearance of growth hormone in overweight youth. Metabolism 2005 54 1374-1383.
37. Jackson AS, Stanforth PR, Gagnon J, Rankinen T, Leon AS, Rao DC, Skinner JS, Bouchard C & Wilmore JH. The effect of sex, age and race on estimating percentage body fat from body mass index: the heritage family study. International Journal of Obesity and Related Metabolic Disorders 2002 26 789-796.
38. Morabia A, Ross A, Curtin F, Pichard C & Slosman DO. Relation of BMI to a dual-energy X-ray absorptiometry measure of fatness. British Journal of Nutrition 1999 82 49-55.
39. Laron Z, Ginsberg S, Lilos P, Arbiv M & Vaisman N. Body composition in untreated adult patients with Laron syndrome (primary GH insensitivity). Clinical Endocrinology (Oxford) 2006 65 114-117.
40. Stefaneanu L, Kovacs K, Horvath E, Asa SL, Losinski NE, Billestrup N, Price J & Vale W. Adenohypophysial changes in mice transgenic for human growth hormone-releasing factor: a histological, immunocytochemical, and electron microscopic investigation. Endocrinology 1989 125 2710-2718.
41. Herrington J, Smit LS, Schwartz J & Carter-Su C. The role of STAT proteins in growth hormone signaling. Oncogene 2000 19 2585-2597.
42. Holmes CN, Iglar KT, McDowell B & Glazier RH. Predictive value of a self-reported history of varicella infection in determining immunity in adults. Canadian Medical Association Journal 2004 171 1195-1196.
43. Holmes CN. Predictive value of a history of varicella infection. Canadian Family Physician 2005 51 60-65.
44. Danovaro-Holliday MC, Gordon ER, Jumaan AO, Woernle C, Judy RH, Schmid DS & Seward JF. High rate of varicella complications among Mexican-born adults in Alabama. Clinical Infectious Diseases 2004 39 1633-1639.
45. Seward JF, Zhang JX, Maupin TJ, Mascola L & Jumaan AO. Contagiousness of varicella in vaccinated cases: a household contact study. Journal of the American Medical Association 2004 292 704-708.
46. Preblud SR. Age-specific risks of varicella complications. Pediatrics 1981 68 14-17.